Alexander E Perl Selected Research

Alexander E Perl Research Topics

Disease

43	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 09/2008
7	Neoplasms (Cancer) 01/2023 - 03/2012
6	Infections 01/2023 - 08/2013
5	Febrile Neutropenia 01/2023 - 01/2019
5	Leukemia 12/2022 - 08/2007
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020 - 08/2013
3	Mucositis 06/2022 - 01/2021
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2018
3	Philadelphia Chromosome 01/2020 - 08/2013
2	Pneumonia (Pneumonitis) 01/2023 - 01/2019
2	Fever (Fevers) 01/2023 - 01/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2022 - 01/2021
1	Frailty 01/2024
1	Diarrhea 01/2023
1	Neutropenia 01/2023
1	Aneuploidy (Aneuploid) 12/2022
1	Pericarditis 11/2021
1	Pain (Aches) 01/2021
1	Myeloid Sarcoma (Chloroma) 01/2021
1	Venous Thromboembolism 01/2020
1	Anemia 10/2019
1	Thrombocytopenia (Thrombopenia) 10/2019
1	Nausea 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Sepsis (Septicemia) 01/2019
1	Residual Neoplasm 01/2018
1	Fatigue 01/2017
1	Cytopenia 08/2013
1	Glioma (Gliomas) 03/2010
1	Disease Progression 09/2008

Drug/Important Bio-Agent (IBA)

14	gilteritinibIBA 03/2024 - 01/2019
9	fms-Like Tyrosine Kinase 3IBA 01/2023 - 01/2018
8	Tyrosine Kinase InhibitorsIBA 03/2024 - 04/2014
6	venetoclaxIBA 02/2024 - 01/2022
6	quizartinibIBA 01/2023 - 04/2014
4	Phosphotransferases (Kinase)IBA 01/2020 - 08/2007
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022 - 11/2020
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2022 - 01/2019
3	Sirolimus (Rapamycin)FDA Link 01/2018 - 11/2009
2	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2017
2	Azacitidine (5 Azacytidine)FDA Link 12/2022 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 06/2022 - 01/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 11/2021
2	midostaurinIBA 01/2022 - 12/2020
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 03/2012
2	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 04/2014
2	TOR Serine-Threonine KinasesIBA 01/2018 - 11/2009
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2018 - 12/2017
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2013 - 03/2010
2	alpha-hydroxyglutarateIBA 06/2013 - 03/2010
1	FF-10101IBA 03/2024
1	Busulfan (Busulfex)FDA Link 01/2023
1	Clofarabine (Clolar)FDA Link 01/2023
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 12/2022
1	ChromatinIBA 12/2022
1	CPX-351IBA 12/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2022
1	Core Binding Factors (Core-Binding Factor)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Decitabine FDA Link 12/2021
1	Colchicine FDA LinkGeneric 11/2021
1	SteroidsIBA 11/2021
1	Leucovorin (Folinic Acid)FDA Link 01/2021
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2021
1	tisagenlecleucelIBA 10/2020
1	Chimeric Antigen ReceptorsIBA 10/2020
1	AntithrombinsIBA 01/2020
1	pexidartinibIBA 01/2020
1	pegaspargase (Oncaspar)FDA Link 01/2020
1	CytokinesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017
1	crenolanibIBA 04/2014
1	Etoposide (VP 16)FDA LinkGeneric 03/2012
1	Mitoxantrone (Novantrone)FDA LinkGeneric 03/2012
1	EnzymesIBA 03/2010
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 03/2010
1	Cytotoxins (Cytolysins)IBA 11/2009
1	Bexarotene (LGD1069)FDA Link 09/2008

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 02/2024 - 11/2009
20	Therapeutics 03/2024 - 03/2012
6	Cell Transplantation 03/2024 - 01/2020
2	Transplantation 01/2023 - 01/2023
2	Length of Stay 06/2022 - 01/2021
2	Induction Chemotherapy 01/2021 - 08/2013
1	Homologous Transplantation 01/2024
1	Nutritional Support (Artificial Feeding) 01/2021
1	Radiotherapy 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Duration of Therapy 10/2019
1	Remission Induction 01/2018
1	Salvage Therapy 01/2018
1	Stem Cell Transplantation 01/2018